Trial intelligence / Profile preview

Capravirine + Viracept + NRTIs in HIV

NCT00006211Phase 2Completed

Sponsor
Agouron Pharmaceuticals
Start
Feb 2000
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Capravirine Arm with Placebo Arm (2 arms). Started Feb 2000; status: completed.

02

Drugs

capravirine
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00006211.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00006211.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call